COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN)

secukinumab
$3950.7700per ML

Strength

150 mg/mL

NDC

00078063941

Classification

Brand

Dosage Form

INJECTION

Route

SUBCUTANEOUS

Last Updated

1/7/2026

Active Ingredients

SECUKINUMAB

Approval Type

Biologic (BLA)

FDA Application

BLA125504

On Market Since

1/21/2015

Pharmacological Classes

Interleukin-17A Antagonist
Interleukin-17A Antagonists

Price History

1W

0.0%

1M

0.0%

3M

0.0%

6M

+7.0%

1Y

+6.8%

3Y

+17.8%

5Y

+37.5%

All

+87.6%